[BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region].
M A TitovaValentina M AlifirovaEkaterina M KamenskihN F MusinaT N NikolaevaDiana Z PaderinaAnastasiia S BoikoSvetlana A IvanovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
Carriers of the indicated genotype had a low rate of MS progression, a lower frequency of relapses and a less pronounced degree of disability with a comparable MS duration, and significantly more often demonstrated a more optimal response to first and second line of DMT.